Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Ujiie

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Dermatology|February 18, 2021
Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatmentInkin Ujiie, Hiroaki Iwata, Norihiro Yoshimoto, et al.
The Australasian Journal of Dermatology|October 27, 2023
Multiple courses of steroid pulse therapy are required in treating acquired idiopathic generalized anhidrosis patients with a large anhidrotic area: A retrospective study of 28 casesKeisuke Imafuku, Teruki Yanagi, Norihiro Yoshimoto, et al.
The Journal of Dermatology|September 8, 2023
Development of a nutritionally balanced, melt-in-the-mouth chocolate for patients with epidermolysis bullosaKosei Nakamura, Shota Takashima, Takuma Nohara, et al.
The Journal of Dermatology|September 27, 2023
Association between weight loss and death in patients with malignant melanoma: A retrospective study of 28 casesArisa Tanaka, Hajime Miyazawa, Teruki Yanagi, et al.
Indian Journal of Dermatology|March 26, 2026
Dermoscopic Features of Porocarcinoma: Report of 11 Cases and Review of the LiteratureKodai Miyamoto, Teruki Yanagi, Takuya Maeda, et al.
Frontiers in Immunology|July 6, 2019
Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid ModelsHideyuki Ujiie, Norihiro Yoshimoto, Ken Natsuga, et al.
Frontiers in Immunology|December 13, 2017
Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen DepletionMayumi Kamaguchi, Hiroaki Iwata, Yuiko Mori, et al.
Clinical Immunology (Orlando, Fla.)|November 3, 2011
Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid modelHideyuki Ujiie, Akihiko Shibaki, Wataru Nishie, et al.
Frontiers in Medicine|February 24, 2018
Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane PemphigoidMayumi Kamaguchi, Hiroaki Iwata, Inkin Ujiie, et al.
The Journal of Pathology|November 15, 2018
Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoidHiroaki Iwata, Mayumi Kamaguchi, Hideyuki Ujiie, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Dermatology|February 18, 2021
Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatmentInkin Ujiie, Hiroaki Iwata, Norihiro Yoshimoto, et al.
The Australasian Journal of Dermatology|October 27, 2023
Multiple courses of steroid pulse therapy are required in treating acquired idiopathic generalized anhidrosis patients with a large anhidrotic area: A retrospective study of 28 casesKeisuke Imafuku, Teruki Yanagi, Norihiro Yoshimoto, et al.
The Journal of Dermatology|September 8, 2023
Development of a nutritionally balanced, melt-in-the-mouth chocolate for patients with epidermolysis bullosaKosei Nakamura, Shota Takashima, Takuma Nohara, et al.
The Journal of Dermatology|September 27, 2023
Association between weight loss and death in patients with malignant melanoma: A retrospective study of 28 casesArisa Tanaka, Hajime Miyazawa, Teruki Yanagi, et al.
Indian Journal of Dermatology|March 26, 2026
Dermoscopic Features of Porocarcinoma: Report of 11 Cases and Review of the LiteratureKodai Miyamoto, Teruki Yanagi, Takuya Maeda, et al.
Frontiers in Immunology|July 6, 2019
Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid ModelsHideyuki Ujiie, Norihiro Yoshimoto, Ken Natsuga, et al.
Frontiers in Immunology|December 13, 2017
Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen DepletionMayumi Kamaguchi, Hiroaki Iwata, Yuiko Mori, et al.
Clinical Immunology (Orlando, Fla.)|November 3, 2011
Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid modelHideyuki Ujiie, Akihiko Shibaki, Wataru Nishie, et al.
Frontiers in Medicine|February 24, 2018
Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane PemphigoidMayumi Kamaguchi, Hiroaki Iwata, Inkin Ujiie, et al.
The Journal of Pathology|November 15, 2018
Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoidHiroaki Iwata, Mayumi Kamaguchi, Hideyuki Ujiie, et al.
Pageof 11